Literature DB >> 11684051

Changes in nitric oxide production and cerebral blood flow before development of hyperbaric oxygen-induced seizures in rats.

T Sato1, Y Takeda, S Hagioka, S Zhang, M Hirakawa.   

Abstract

The predictive value of increase in cerebral blood flow (CBF) was examined to detect hyperbaric oxygen (HBO(2))-induced electrical discharge in artificially ventilated rats at three PaCO(2) levels under 5 atmospheric pressures. The possible involvement of NO production in the mechanism of the increase in CBF was also assessed by measurement of major NO metabolites (NO(2)(-) plus NO(3)(-)) using a microdialysis technique at the left parietal cortex during HBO(2) exposure. The onset times of electrical discharge, measured in the right frontal region, were significantly prolonged and shortened in the low PaCO(2) group (79+/-21 min) and high PaCO(2) group (27+/-7 min), respectively, compared to that in the normal PaCO(2) group (37+/-5 min). Increase in CBF (200% of the pre-exposure level) was observed in every animal and was sustained until the appearance of electrical discharge. The onset time of increase in CBF was closely related to that of electrical discharge (R(2)=0.987), and the durations of increase in CBF were almost identical (11-14 min in mean) regardless of the PaCO(2) level. The level of NO(2)(-) plus NO(3)(-) was unaffected by the initiation of HBO(2) exposure and simultaneously increased up to 246+/-59% of control level with the onset of increase in CBF. There was a close relationship between changes in CBF and levels of NO(2)(-) plus NO(3)(-) (R(2)=0.544). These results indicate that monitoring of CBF is useful for the prediction of electrical discharge in artificially ventilated rats regardless of their PaCO(2) levels and that the increase in NO production is related to the mechanism of increase in CBF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684051     DOI: 10.1016/s0006-8993(01)02984-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Nitric oxide-mediated central sympathetic excitation promotes CNS and pulmonary O₂ toxicity.

Authors:  Ivan T Demchenko; Alexander N Moskvin; Alexander I Krivchenko; Claude A Piantadosi; Barry W Allen
Journal:  J Appl Physiol (1985)       Date:  2012-03-22

2.  An anxiolytic-like effect of hyperbaric oxygen in the mouse light/dark exploration test.

Authors:  Edina L Carlile; Donald Y Shirachi; Raymond M Quock
Journal:  Life Sci       Date:  2011-12-01       Impact factor: 5.037

Review 3.  Integrative Role of Hyperbaric Oxygen Therapy on Healthspan, Age-Related Vascular Cognitive Impairment, and Dementia.

Authors:  Priya Balasubramanian; Jordan Delfavero; Adam Nyul-Toth; Amber Tarantini; Rafal Gulej; Stefano Tarantini
Journal:  Front Aging       Date:  2021-09-23

4.  Alteration of striatal dopamine levels under various partial pressure of oxygen in pre-convulsive and convulsive phases in freely-moving rats.

Authors:  Cécile Lavoute; Michel Weiss; Jean-Jacques Risso; Jean-Claude Rostain
Journal:  Neurochem Res       Date:  2013-12-22       Impact factor: 3.996

5.  Pressure-related increase of asymmetric dimethylarginine caused by hyperbaric oxygen in the rat brain: a possible neuroprotective mechanism.

Authors:  Emin Ozgür Akgül; Erdinc Cakir; Omer Ozcan; Halil Yaman; Yasemin Gülcan Kurt; Sükrü Oter; Ahmet Korkmaz; Cumhur Bilgi; Mehmet Kemal Erbil
Journal:  Neurochem Res       Date:  2007-06-13       Impact factor: 3.996

6.  Endothelial nitric oxide synthase expression is progressively increased in primary cerebral microvascular endothelial cells during hyperbaric oxygen exposure.

Authors:  Xiongfei Xu; Zhongzhuang Wang; Quan Li; Xiang Xiao; Qinglin Lian; Weigang Xu; Xuejun Sun; Hengyi Tao; Runping Li
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

7.  Exhaled nitric oxide is decreased by exposure to the hyperbaric oxygen therapy environment.

Authors:  Zudin A Puthucheary; Jia Liu; Michael Bennett; Barbara Trytko; Sharron Chow; Paul S Thomas
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.